Effects of metrifonate on cognitive decline in Alzheimer disease: A double-blind, placebo-controlled, 6-month study

被引:36
作者
Becker, RE [1 ]
Colliver, JA [1 ]
Markwell, SJ [1 ]
Moriearty, PL [1 ]
Unni, LK [1 ]
Vicari, S [1 ]
机构
[1] So Illinois Univ, Sch Med, Dept Psychiat, Springfield, IL USA
关键词
Alzheimer disease; acetylcholinesterase inhibitors; cognitive decline; memory; metrifonate; dichlorvos;
D O I
10.1097/00002093-199803000-00009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Forty-seven patients with probable Alzheimer disease (AD) completed a 6 month double-blind study to compare metrifonate with placebo. The Alzheimer Disease Assessment Scale cognitive subscale score of the metrifonate group treated to a 50-70% inhibition of red blood cell acetylcholinesterase activity differed significantly from the placebo group score by 1.8 points (p < 0.03) due to a deterioration in cognitive performance in the placebo group (p < 0.01). Statistically significant deterioration also occurred in the Mini-Mental State Examination scores (p < 0.01) in the placebo-treated group. Adverse effects were uncommon and did not require adjustment of the dose of metrifonate or discontinuation of treatment. These findings extend our previous report of a favorable effect of metrifonate on cognitive symptoms in AD by showing clinical, not only statistical, significance.
引用
收藏
页码:54 / 57
页数:4
相关论文
共 9 条
[1]   Double-blind placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease [J].
Becker, RE ;
Colliver, JA ;
Markwell, SJ ;
Moriearty, PL ;
Unni, LK ;
Vicari, S .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1996, 10 (03) :124-131
[2]  
BECKER RE, 1988, CURRENT RES ALZHEIME, P1
[3]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[4]  
HACHINSKI VC, 1974, LANCET, V2, P207
[5]   RAPID, SIMPLE RADIOMETRIC ASSAY FOR CHOLINESTERASE, SUITABLE FOR MULTIPLE DETERMINATIONS [J].
JOHNSON, CD ;
RUSSELL, RL .
ANALYTICAL BIOCHEMISTRY, 1975, 64 (01) :229-238
[6]  
KHATCHATURIAN Z, 1992, NEUROBIOL AGING, V12, P197
[7]  
MCKHANN G, 1990, NEUROLOGY, V28, P561
[8]  
ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356
[9]  
UNNI LK, 1992, IMACS INT S MATH MOD